Overview

• Northern TK Venture (NTK), a subsidiary of IHH Healthcare, has increased its damages claim against Daiichi Sankyo from JPY 20 billion to approximately JPY 200 billion (~₹11,800 crore).
• The claim stems from allegations that Daiichi Sankyo obstructed NTK's 2018 open offer to acquire additional shares in Fortis Healthcare, causing significant financial losses.
• NTK’s revised claim includes ₹2.7 million for defamation and accrued interest, reflecting an escalation in the legal dispute.
• An expert report by Osborne Partners in February 2025 quantified potential damages under three scenarios, ranging from ₹4.24 billion to ₹109.3 billion.
• The next hearing in the Tokyo District Court is scheduled for July 11, 2025, as the high-stakes cross-border litigation continues.